DENTAID EXPERTISE
News for dentistry professionals
PERIO·AID. THE CHOICE IS YOURS IN EVERY SITUATION
11 Oct 2016
The Perio·Aid® range has updated its image in order to differentiate the range of products that comprises it.
The official presentation of the new Perio·Aid® image took place at the 50th Meeting of the Spanish Society of Periodontology and Osseointegration (SEPA) held in Valencia.
Perio·Aid® is the oral antiseptic indicated for periodontal and peri-implant disease treatment and maintenance.
Its unique formulation, containing the combination of two antiseptics, Chlorhexidine (CHX) and Cetylpyridinium Chloride (CPC), obtains maximum efficacy in the treatment and control of periodontal and peri-plant diseases.
Perio·Aid®
presents two different concentrations that guarantee the best solution in every
situation.
THE UNIQUE FORMULATION OF PERIO·AID® IS BASED ON A COMBINATION OF TWO ANTISEPTICS: CHLORHEXIDINE AND CETYLPYRIDINIUM CHLORIDE
WHEN CARE IS NEEDED
Perio·Aid® 0.12 Treatment. (CHX 0.12% + CPC 0.05%)
- Used for active infections, it helps to TREAT periodontal and/or peri-implant disease, as it assists in the elimination of the pathogenic biofilm that causes these diseases.
- Available in various forms according to use and indication:
- Gel. Formulation used for application as a dental gel with a toothbrush, and as a topical gel for application with gauze or a clean finger in areas requiring antiseptic protection.
- Spray. Especially indicated for hard-to-reach areas (for example the rear of the oral cavity) or for those who cannot properly use mouthwash.
WHEN CONTROL IS NEEDED
Perio·Aid® 0.05 Maintenance and Control. (CHX 0.05%+ CPC 0.05%)
- Helps keep pathogenic biofilm UNDER
CONTROL daily.
- Its formulation, with
low-concentration CHX plus CPC, is scientifically proven to have the same
efficacy as formulations containing higher concentrations (CHX 0.12%).
- May
be used long term with minimal side effects.
- Especially indicated for maintenance to prevent the development of periodontal and peri-implant diseases in patients at risk:
RELATED ARTICLES
14 Oct 2021
The latest scientific developments on CPC in recent international conferences
DENTAID participates in different international scientific meetings, where the importance of the mouth during the current COVID-19 impacted landscape…
21 May 2021
The 2nd National Multidisciplinary Congress on COVID-19 of the Scientific Societies of Spain highlights the importance of oral health and its impact on SARS-CoV-2
After a year of the pandemic, the 2nd National Multidisciplinary Congress on COVID-19 of the Scientific Societies of Spain brought together multiple…
14 Jul 2020
THE IDEAL FORMULA TO HELP REPAIR AND HEAL DAMAGED ORAL MUCOSA
In recent years, the number of mouth surgeries has increased due to the growth in implant interventions, amongst other reasons. In all these…
Sign up for the DENTAID Expertise newsletter
Sign up for the newsletter
Sign up for the DENTAID Expertise newsletter
| Data controller | DENTAID, S.L. LABORATORIOS DE PREVENCIÓN E HIGIENE BUCAL, SLU (“PHB”). |
|---|---|
| Purpose of data processing | To respond to a query from the interested party with the advice of a specialist. |
| Legitimisation of data processing | Your consent to process your personal data. |
| Recipients of disclosure or transfer | Data is not disclosed or transferred internationally. |
| Rights of the interested persons | To access, rectify and delete their data, and to exercise other rights as set out in the additional information. |
| Additional information | You can consult additional and detailed information on data protection at this link. |
The content shown below corresponds to Spain and to products sold under country-specific registration.
OKThe content shown below corresponds to Spain and to products sold under country-specific registration.
OK